Epidermal squamous cell carcinoma is one of the most common forms of human cancer and the incidence is increasing. Thus, skin cancer is an important health concern and advanced disease recurs and is life- threatening and disfiguring. Because skin cancer development involves multiple events over a long period of time, prevention is an important and preferred option. For this reason there is a major ongoing effort to identify preventive agents that can be taken orally or applied on the skin surface. In particula, we have focused on the impact of sulforaphane (SFN), derived from broccoli, on function of the Ezh2 Polycomb Group (PcG) protein. PcG proteins are important epigenetic regulators that methylate and ubiquitinate specific histones to produce closed chromatin and silence tumor suppressor gene expression. Key polycomb group proteins, including Ezh2, are overexpressed in skin cancer and this drives silencing of p21Cip1 and other tumor suppressors leading to enhanced tumor cell survival. We have shown that SFN suppresses Ezh2 which leads to increased p21Cip1 expression. These changes ultimately lead to cessation of skin cancer cell proliferation and increased cancer cell death. Our exciting unpublished preliminary studies suggest that a pathway that includes two master regulators of keratinocyte survival and stem cell fate, DNp63a and KLF4, regulates Ezh2 level. These proteins have not been previously considered as important prevention targets. We hypothesize that in cancer cells a DNp63a, KLF4 pathway stimulates Ezh2 gene expression which, in turn, acts to reduce p21Cip1 expression leading to increased cancer cell survival. We further propose that SFN inhibits events in this pathway to reduce Ezh2 expression and increase tumor suppressor expression. Experiments in this proposal revolve around well-defined translation-relevant goals.
Specific Aim 1 studies how DNp63a and KLF4 regulate Ezh2 level.
Specific Aims 2 examines SFN regulation of this pathway.
Specific Aim 3 examines Ezh2 regulation of p21Cip1 expression, and Specific Aim 4 address the impact of Ezh2 and SFN treatment on tumor formation in vivo. These studies are highly relevant to understanding the biological role of SFN in preventing skin cancer formation.
Epidermal squamous cell carcinoma ranks among the most common forms of human cancer and is an important health concern. Because skin cancer develops over a long period of time, prevention is an important and preferred option to reduce skin cancer rate. Polycomb proteins are important epigenetic regulators of gene expression that are highly overexpressed in skin cancer and act to enhance skin cancer cell survival. In the present study we examine the mechanism whereby sulforaphane, a dietary agent derived from broccoli, reduces expression of polycomb group proteins leading to enhanced cancer cell death.
|Rorke, Ellen A; Adhikary, Gautam; Young, Christina A et al. (2015) Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype. J Invest Dermatol 135:170-80|
|Scharadin, Tiffany M; Adhikary, Gautam; Shaw, Kristin et al. (2014) Pericentrosomal localization of the TIG3 tumor suppressor requires an N-terminal hydrophilic region motif. J Invest Dermatol 134:1220-9|
|Eckert, Richard L; Adhikary, Gautam; Balasubramanian, Sivaprakasam et al. (2013) Biochemistry of epidermal stem cells. Biochim Biophys Acta 1830:2427-34|
|Choudhury, Subhasree Roy; Balasubramanian, Sivaprakasam; Chew, Yap Ching et al. (2011) (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells. Carcinogenesis 32:1525-32|
|Eckert, Richard L; Adhikary, Gautam; Rorke, Ellen A et al. (2011) Polycomb group proteins are key regulators of keratinocyte function. J Invest Dermatol 131:295-301|
|Balasubramanian, Sivaprakasam; Chew, Yap Ching; Eckert, Richard L (2011) Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells. Mol Pharmacol 80:870-8|
|Balasubramanian, Sivaprakasam; Eckert, Richard L (2007) Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol 224:214-9|